Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients

doi:10.3748/wjg.v27.i31.5247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6356)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

439

WORD

168

HTML

2638

Figures (1-1)

191

Tables (1-4)

198

Sum=3634

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

364

Download

758

Sum=1122

Publishing Process of This Article

Item

Count

Browse

458

Download

1142

Sum=1600

Aug 21, 2021 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Aug 21, 2021; 27(31): 5247-5258
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5247

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart. TT: Tailored therapy; CT: Concomitant regimen; S: Sensitive; R: Resistance; PAC: Pancreatic adenocarcinoma; PBMT: Bismuth-containing quadruple combination; ITT: Intention-to-treat; PP: Per-protocol; H. pylori: Helicobacter pylori.

Citation: Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Kim JH, Seo JY, Park DK. Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients. World J Gastroenterol 2021; 27(31): 5247-5258
URL: https://www.wjgnet.com/1007-9327/full/v27/i31/5247.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i31.5247